跳至主導覽
跳至搜尋
跳過主要內容
臺北醫學大學 首頁
說明與常見問題
English
中文
首頁
專家檔案
研究單位
專案
研究成果
資料集
活動
按專業知識、姓名或所屬機構搜尋
查看斯高帕斯 (Scopus) 概要
吳 忠擇
副教授
,
內分泌暨新陳代謝科
主治醫師
,
衛生福利部雙和醫院
https://orcid.org/0000-0001-6118-6070
電子郵件
chungze
tmu.edu
tw
h-index
774
引文
16
h-指數
按照存儲在普爾(Pure)的出版物數量及斯高帕斯(Scopus)引文計算。
2006
2024
每年研究成果
概覽
指紋
網路
專案
(7)
研究成果
(96)
資料集
(2)
類似的個人檔案
(6)
指紋
查看啟用 Chung-Ze Wu 的研究主題。這些主題標籤來自此人的作品。共同形成了獨特的指紋。
排序方式
重量
按字母排序
Biochemistry, Genetics and Molecular Biology
Insulin Release
100%
Insulin Resistance
85%
Glucose Blood Level
62%
Body Mass
40%
Glucose Level
28%
Blood Pressure
27%
Triglyceride
27%
Glucose Tolerance Test
22%
Glucose Test
22%
Leukocyte Count
22%
Insulin Sensitivity
16%
HDL-Cholesterol
16%
Urokinase
16%
Insulin Blood Level
15%
Leukocyte
14%
Low Drug Dose
14%
C-Reactive Protein
14%
Systolic Blood Pressure
14%
Impaired Glucose Tolerance
14%
Alanine
13%
Transaminase
13%
Mouse Model
11%
Steady State
11%
Platelet Count
9%
Adiponectin
9%
Urokinase Receptor
9%
Eicosanoid Receptor
9%
Gamma-Glutamyl Transpeptidase
9%
Bone Density
9%
Gliclazide
9%
Diastolic Blood Pressure
8%
Low-Density Lipoprotein
7%
Tumor Necrosis Factor
7%
Waist Circumference
7%
Triacylglycerol Level
7%
Cell Function
7%
Glomerulus Filtration
7%
Cohort Study
7%
Platelet
6%
Mass Screening
6%
Cross Sectional Study
6%
Normal Human
6%
Homeostasis
5%
Factor Analysis
5%
Insulin Response
5%
Postmenopause
5%
Prevalence
5%
Thyroid-Stimulating Hormone
5%
Medicine and Dentistry
Metabolic Syndrome
62%
Maturity Onset Diabetes of the Young
51%
Body Mass Index
30%
Insulin Release
30%
Insulin Resistance
23%
Blood Pressure
17%
Multiple Linear Regression Analysis
17%
Cardiovascular Disease
15%
Diabetes
14%
Urokinase Receptor
13%
Patient with Type 2 Diabetes
13%
Prevalence
12%
Triacylglycerol
12%
Systolic Blood Pressure
12%
Urokinase
11%
Insulin Sensitivity
10%
Receptor
9%
Gamma-Glutamyl Transpeptidase
9%
Heart Muscle Perfusion
9%
Diabetes Mellitus
9%
High Density Lipoprotein Cholesterol
8%
Steady State
8%
Diastolic Blood Pressure
7%
Biopsy
6%
Homeostatic Model Assessment
6%
Elderly Population
6%
Thyrotropin
6%
Oral Antidiabetic Agent
6%
Cross Sectional Study
6%
Low Density Lipoprotein Cholesterol
5%
Type 2 Diabetes
5%
Glycemic Control
5%
Oral Glucose Tolerance Test
5%
Adiponectin
5%
Hemoglobin A1c
5%
Medicine
5%
Glucose Tolerance
5%
Adipocytokine
5%
Middle Age
5%
Metastatic Carcinoma
5%
Pharmacology, Toxicology and Pharmaceutical Science
Metabolic Syndrome X
62%
Non Insulin Dependent Diabetes Mellitus
43%
Insulin Resistance
41%
Triacylglycerol
19%
Diabetes Mellitus
15%
Impaired Glucose Tolerance
14%
Urokinase
14%
Prevalence
13%
Urokinase Receptor
13%
High Density Lipoprotein Cholesterol
11%
Mouse Model
11%
Receptor
9%
Gamma Glutamyltransferase
9%
Alanine Aminotransferase
9%
Retinol Binding Protein 4
9%
Repaglinide
9%
Diabetic Nephropathy
9%
Gliclazide
9%
Cardiovascular Disease
8%
Cross-Sectional Study
6%
Coronary Artery Disease
6%
Low Density Lipoprotein Cholesterol
6%
Biological Marker
6%
Glycosylated Hemoglobin
6%
Adipocytokine
5%
Nonalcoholic Fatty Liver
5%
Pathophysiology
5%
Glucose Intolerance
5%
Cohort Study
5%
Kidney Disease
5%